United States Veterinary Biologicals Market was valued at USD 1.8 Billion in 2022 and is projected to reach USD 3.0 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030.
The US Veterinary Biologicals Market has experienced significant growth in recent years due to increased awareness of animal health, advancements in veterinary medicine, and rising demand for pet care. Veterinary biologicals, such as vaccines, immunotherapeutics, and diagnostic products, are vital in ensuring the health and well-being of both companion and livestock animals. As the demand for these products continues to increase, industries across the country are looking for cutting-edge solutions to meet the growing needs of animal healthcare.
The market can be divided into several types of veterinary biological products, each catering to specific needs. The largest segment is vaccines, which are essential in preventing infectious diseases in animals. Vaccines are commonly administered to livestock, poultry, and pets, and they play a pivotal role in controlling outbreaks of diseases such as rabies, parvovirus, and avian influenza. In addition, immunotherapeutics, which include treatments like monoclonal antibodies and cytokine therapies, are gaining traction in treating various animal ailments. Diagnostic products also contribute significantly to the market, allowing veterinarians to accurately diagnose diseases and ensure timely treatment.
From an industrial perspective, the demand for veterinary biologicals is driven by both the pet care industry and the livestock farming sector. Pet ownership in the US is at an all-time high, leading to a surge in demand for preventive care, treatments, and diagnostics. Livestock farming, too, remains a major driver of market growth, with vaccines and biologics being essential in preventing the spread of diseases that can devastate entire herds. As the agriculture industry faces growing pressures to maintain high standards of animal health, veterinary biologicals become more critical in ensuring the sustainability and profitability of farms.
The Veterinary Biologicals Market is also impacted by technological advancements and research in the development of novel treatments. Emerging biologics that target genetic diseases and offer customized therapies are expected to gain momentum in the coming years. Furthermore, the increasing adoption of precision medicine, which tailors treatments based on individual animal needs, has further increased the demand for high-quality, specialized veterinary biological products.
As the industry continues to evolve, veterinary biologicals are becoming an essential aspect of animal healthcare. Companies operating within this space must continue to innovate to meet the growing requirements of industries relying on these products to maintain the health of animals across the United States.
Get an In-Depth Research Analysis of the US Veterinary Biologicals Market Size And Forecast [2025-2032]
Boehringer Ingelheim
Zoetis
Virbac
Inc.
Heska Corporation
Kyoto Biken
FATRO
Elanco
Merck Animal Health
China Animal Husbandry Industry Co.
Ltd.
Tianjin Ringpu Bio-technology Co.
Ltd.
Pulike Biological Engineering
Inc.
Jinyu Bio-Technology Co.
Ltd.
Tecon Biology Co.
Ltd.
Shanghai Hile Bio-Technology Co.
Ltd.
Jinhe Biotechnology Co.
Ltd.
Shandong Lukang Pharmaceutical Co.
Ltd.
Wuhan Keqian Biology Co.
Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Veterinary Biologicals Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Veterinary Biologicals Market
Vaccines
Antisera
Other Biological Products
Companion Animals
Livestock
Other Animals
Infectious Diseases
Non-infectious Diseases
Preventive Care
Injectable
Oral
Topical
Veterinary Hospitals
Veterinary Clinics
Animal Farms
Research Laboratories
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Veterinary Biologicals Market Research Analysis
1. Introduction of the US Veterinary Biologicals Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Veterinary Biologicals Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Veterinary Biologicals Market, By Type
6. US Veterinary Biologicals Market, By Application
7. US Veterinary Biologicals Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Veterinary Biologicals Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/